Charles Schwab Investment Management Inc Ironwood Pharmaceuticals Inc Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,904,271 shares of IRWD stock, worth $8.47 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,904,271

Previous 1,539,430 23.7%

Holding current value

$8.47 Million

Previous $10 Million 22.03%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$3.93 - $7.04 $1.43 Million - $2.57 Million	364,841 Added 23.7%	1,904,271 $7.83 Million
Q2 2024 Aug 12, 2024	BUY	$5.58 - $8.61 $820,410 - $1.27 Million	147,027 Added 10.56%	1,539,430 $10 Million
Q1 2024 May 08, 2024	BUY	$8.32 - $15.45 $863,200 - $1.6 Million	103,750 Added 8.05%	1,392,403 $12.1 Million
Q4 2023 Feb 06, 2024	BUY	$8.79 - $11.51 $508,580 - $665,957	57,859 Added 4.7%	1,288,653 $14.7 Million
Q3 2023 Nov 08, 2023	SELL	$8.25 - $11.35 $1.16 Million - $1.6 Million	-140,974 Reduced 10.28%	1,230,794 $11.9 Million
Q2 2023 Aug 09, 2023	SELL	$10.1 - $11.6 $1.36 Million - $1.57 Million	-134,923 Reduced 8.95%	1,371,768 $14.6 Million
Q1 2023 May 11, 2023	BUY	$10.37 - $12.56 $4.34 Million - $5.26 Million	418,419 Added 38.45%	1,506,691 $15.9 Million
Q4 2022 Feb 13, 2023	BUY	$9.9 - $12.43 $686,406 - $861,821	69,334 Added 6.8%	1,088,272 $13.5 Million
Q3 2022 Nov 14, 2022	SELL	$10.14 - $12.38 $1.07 Million - $1.31 Million	-105,800 Reduced 9.41%	1,018,938 $10.6 Million
Q2 2022 Aug 15, 2022	SELL	$11.05 - $12.72 $3.35 Million - $3.86 Million	-303,443 Reduced 21.25%	1,124,738 $13 Million
Q1 2022 May 13, 2022	SELL	$10.61 - $12.88 $374,639 - $454,792	-35,310 Reduced 2.41%	1,428,181 $18 Million
Q4 2021 Feb 11, 2022	BUY	$10.86 - $13.95 $254,189 - $326,513	23,406 Added 1.63%	1,463,491 $17.1 Million
Q3 2021 Nov 16, 2021	BUY	$11.92 - $13.92 $3.09 Million - $3.6 Million	258,897 Added 21.92%	1,440,085 $18.8 Million
Q2 2021 Aug 16, 2021	SELL	$10.16 - $13.11 $87,447 - $112,837	-8,607 Reduced 0.72%	1,181,188 $15.2 Million
Q1 2021 May 17, 2021	BUY	$9.04 - $11.86 $319,554 - $419,239	35,349 Added 3.06%	1,189,795 $13.3 Million
Q4 2020 Feb 16, 2021	BUY	$9.05 - $12.2 $112,808 - $152,073	12,465 Added 1.09%	1,154,446 $13.2 Million
Q3 2020 Nov 13, 2020	BUY	$8.99 - $10.74 $331,802 - $396,391	36,908 Added 3.34%	1,141,981 $10.3 Million
Q2 2020 Aug 14, 2020	BUY	$9.14 - $11.97 $1.09 Million - $1.43 Million	119,395 Added 12.11%	1,105,073 $11.4 Million
Q1 2020 May 15, 2020	BUY	$8.58 - $14.01 $236,155 - $385,611	27,524 Added 2.87%	985,678 $9.95 Million
Q4 2019 Feb 07, 2020	BUY	$8.22 - $14.0 $183,996 - $313,376	22,384 Added 2.39%	958,154 $12.8 Million
Q3 2019 Nov 08, 2019	BUY	$8.59 - $10.96 $250,080 - $319,078	29,113 Added 3.21%	935,770 $8.03 Million
Q2 2019 Aug 09, 2019	BUY	$9.8 - $12.89 $551,573 - $725,487	56,283 Added 6.62%	906,657 $9.92 Million
Q1 2019 May 14, 2019	BUY	$8.27 - $12.73 $709,938 - $1.09 Million	85,845 Added 11.23%	850,374 $11.5 Million
Q4 2018 Feb 14, 2019	SELL	$7.8 - $16.13 $140,361 - $290,259	-17,995 Reduced 2.3%	764,529 $7.92 Million
Q3 2018 Nov 13, 2018	BUY	$14.31 - $17.65 $858,156 - $1.06 Million	59,969 Added 8.3%	782,524 $14.4 Million
Q2 2018 Aug 08, 2018	BUY	$11.83 - $16.2 $522,377 - $715,343	44,157 Added 6.51%	722,555 $13.8 Million
Q1 2018 May 07, 2018	BUY	$11.13 - $13.63 $403,774 - $494,469	36,278 Added 5.65%	678,398 $10.5 Million
Q4 2017 Jan 17, 2018	BUY	$12.16 - $14.58 $34,303 - $41,130	2,821 Added 0.44%	642,120 $9.63 Million
Q3 2017 Nov 13, 2017	BUY	$12.07 - $14.87 $7.72 Million - $9.51 Million	639,299	639,299 $10.1 Million

Others Institutions Holding IRWD

# of Institutions

237

Shares Held

162M

Call Options Held

11.2M

Put Options Held

9.1K

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $682M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Ironwood Pharmaceuticals Inc Transaction History